Background and Purpose-The mechanisms involved in the neurological deterioration of acute lacunar strokes are unknown. Although accumulating evidence suggests that glutamate release plays a role in the progression of territorial infarctions, it remains to be established whether excitotoxicity also participates in lacunar stroke progression. We investigated whether excitatory and inhibitory amino acid concentrations in blood predict subsequent progressive motor deficits in lacunar infarctions. Methods-We studied 113 consecutive patients with lacunar infarct, defined by clinical and computed tomography/ magnetic resonance imaging criteria, within the first 24 hours after stroke onset. Neurological deterioration was defined as a decrease of Ն1 points in the motor items of the Canadian Stroke Scale in the first 48 hours after admission. Glutamate, glycine, and GABA were determined by high-performance liquid chromatography in plasma samples obtained on admission. Predictive values, sensitivity, specificity, and accuracy of specific glutamate and GABA concentrations and glutamateϫglycine/GABA index for progression of lacunar stroke were calculated. Results-Twenty-seven patients (23.9%) had neurological worsening. Plasma concentrations of glutamate (253Ϯ70 versus 123Ϯ73 mol/L, meanϮSD) were higher and those of GABA (140Ϯ63 versus 411Ϯ97 nmol/L) were lower in the progressing group than in the nonprogressing group (both PϽ0.001). Glutamate concentrations Ͼ200 mol/L and GABA levels Ͻ240 nmol/L had a positive predictive value for neurological deterioration of 67% and 84%, respectively. A excitotoxic index Ͼ106 had a positive predictive value of 85%. Conclusions-These findings suggest that an imbalance between the glutamate and GABA concentrations may play a role in the pathophysiology of progressing lacunar infarctions.
L acunar infarctions have a better prognosis than other stroke subtypes. 1 However, a progressing course during the acute phase, leading to a more severe prognosis, [2] [3] [4] [5] [6] [7] [8] is observed in 25% to 35% of patients. No reliable predictors for neurological worsening in lacunar infarctions currently exist, although some clinical factors have been associated with progression in a few published studies. [5] [6] [7] [8] A better understanding of the mechanisms involved in progression could lead to the development of new therapeutic strategies in lacunar strokes. Some authors have suggested that lacunar strokes be excluded from clinical trials on neuroprotection in the belief that glutamate and GABA receptors are not present in white matter. 9, 10 However, the molecular mechanisms underlying neurological deterioration in acute lacunar strokes are unknown. Although accumulating evidence suggests that the release of glutamate plays a role in the progression of territorial infarctions, 11 it remains to be established whether excitotoxicity also plays a role in lacunar stroke progression. In this study, we investigated the association of excitatory and inhibitory amino acid concentrations in plasma and the progression of neurological deficit in lacunar infarctions.
Subjects and Methods
We studied 113 consecutive patients (men, 56.6%; meanϮSD age, 69.7Ϯ9.2 years) with a lacunar infarction within 24 hours of the onset of symptoms and 50 healthy control subjects. Patients were admitted in 2 university hospitals (69 and 44 patients) and were selected from a total of 284 patients included between October 1997 and December 1999 in a prospective stroke data bank of patients diagnosed as having lacunar infarction. The aim was to study new biochemical markers of neurological deterioration; hence, frozen plasma samples obtained at admission from each patient were stored in appropriate conditions. The protocol was approved by the ethics committees, and informed consent was given by patients or their relatives. Lacunar infarction was diagnosed if the patient had 1 of the characteristic clinical lacunar syndromes, 2, 12 neurological deficit lasting Ͼ24 hours, no evidence of cerebral cortical dysfunction, and computed tomography/magnetic resonance imaging (CT/MRI) that was normal or showed a deep focal infarction in an appropriate location with a diameter Յ15 mm. Exclusion criteria, for the purpose of this investigation, were established after the completion of the data bank. Reasons for exclusion were a lack of stored blood samples in 30 patients, no follow-up CT scan or MRI in 53 patients, and admission Ͼ24 hours after stroke onset in 88 patients. The exclusion of patients was agreed upon by 1 investigator from each center (J.S. and J.C.) before neuroimaging evaluation and amino acid determination.
The control group, which has already been described, 13 included subjects without neurological disorders subjected to epidural anesthesia (29 men and 21 women; mean age, 56Ϯ17 years). Plasma and cerebrospinal fluid (CSF) samples were obtained.
Stroke severity was quantified by an experienced neurologist using the Canadian Stroke Scale (CSS) at admission and 48 hours after inclusion. The CSS measures level of consciousness (alertϭ3, drowsyϭ1.5); speech (normalϭ1, expressive deficitϭ0.5; receptive deficitϭ0); orientation (orientedϭ1, disoriented or not applicableϭ0); facial paresis (noneϭ0.5, presentϭ0); weakness in arm, hand, and leg (noneϭ1.5, mildϭ1, significantϭ0.5, totalϭ0; scored individually for each item), with a total score ranging from 1.5 (maximum deficit) to 10 (absence of deficit). 14 Following already published criteria aimed at giving the highest sensitivity and specificity, progressing stroke was diagnosed when the CSS score dropped Ն1 points during the first 48 hours after admission. 14, 15 According to the diagnostic criteria of lacunar stroke, only changes in the motor items of the CSS were considered. Outcome at 3 months was evaluated with the modified Rankin scale and the Barthel Index. Measurements at hospital discharge were taken as final outcome scores in 5 patients who failed to attend the appointment scheduled for 3 months after stroke.
CT scan was carried out at admission, and CT or MRI was repeated between days 3 and 7 of hospitalization. The control CT, or MRI when performed, was used as the gold standard in identifying lacunar infarcts. Parenchymal topography was assessed from the control examination by the same radiologist (J.M.P.), who had no knowledge of the patients' clinical and biochemical results. Infarct location was classified as (1) internal capsule, (2) corona radiata, (3) centrum semiovale, (4) caudate nucleus, (5) putamen and globus pallidus nucleus, (6) thalamus, (7) midbrain, (8) pons, and (9) medulla in accordance with established template mapping. 16, 17 For the purpose of this study, the thalamus was included, along with caudate nucleus, putamen, and globus pallidus, as "basal ganglia." Infarct volume was not calculated because of the unreliability of CT in measuring small infarcts. Blood chemistry test, 12-lead electrocardiograms, chest radiography, and arterial supra-aortic trunk examination (color-coded duplex sonography in 93 patients, digital substraction angiography in 12, and MRI angiography in 8) were also performed in all patients. Transcranial Doppler was carried out systematically in 1 hospital (44 patients) following a protocol reported elsewhere. 18 The suspected cause of lacunar infarctions was classified as large-artery atherosclerosis, cardioembolism, and smallvessel disease, following the Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria. 19 Only patients who had a systolic blood pressure Ն220 mm Hg or a diastolic blood pressure Ն120 mm Hg received hypotensive drugs in the first 48 hours after admission. Treatment with insulin for hyperglycemia (blood glucose Ͼ160 mg/dL) and with intravenous metamizol for hyperthermia (body temperature Ͼ37.5°C) was initiated early after hospitalization. Subcutaneous low-dose heparin as a prophylaxis against pulmonary thromboembolism and antiplatelet drugs were prescribed. Anticoagulants were given to patients with a major cardioembolic source but not as treatment of progressing lacunar stroke. Two patients received a placebo as part of a short-term clinical trial, and none was treated with recombinant tissue plasminogen activator.
Laboratory Tests
Blood samples were taken on admission in the Emergency Department in glass test tubes containing potassium edtate. Suspensions of plasma were centrifuged at 3000g for 5 minutes and stored at Ϫ80°C. Glutamate, glycine, and GABA were quantified by highperformance liquid chromatography as previously described. 11 These measurements were made by technicians from an independent laboratory who were unaware of the clinical outcome and neuroimaging findings. The excitotoxic index was calculated as glutamate (in mol/L) times glycine (in mol/L) divided by GABA (in nmol/L), following the description of Globus et al. 20 
Statistical Analyses
Proportions between progressing and nonprogressing lacunar infarcts were compared by use of the 2 test. Continuous variables are expressed as meanϮSD and were compared by Student's t test or the Mann-Whitney test as appropriate. The Kruskal-Wallis test was used to compare amino acid concentrations between 5 groups of patients with different degrees of improvement or worsening in CSS score between admission and 48 hours; absolute differences were as follows: group 1, Ն2; group 2, 1.5 and 1.0; group 3, 0.5, 0, and Ϫ0.5; group 4, Ϫ1.0 and Ϫ1.5; and group 5, ՅϪ2.0.
We used cutoff values, as described by Robert et al, 21 to estimate the sensitivity, specificity, predictive values, and accuracy (with 95% confidence intervals [CIs]) of a specific concentration of plasma glutamate and GABA and of a particular cutoff in excitotoxic index for progressing lacunar stroke. This method is a probabilistic technique based on Bayes' rules that provides the maximum probability of a correct classification. The importance of amino acids in the progression of lacunar stroke was assessed by logistic regression analysis with adjustment for those baseline variables related to neurological worsening in the univariate analysis. Amino acids were included as categorical variables because the cutoffs meant that there was a lack of linearity of the odds ratios (ORs; 1ϭhigh, 0ϭlow). The potential interaction between glutamate and GABA concentrations was analyzed.
Results
Of the 113 patients studied, 27 (23.9%) showed neurological worsening during the first 48 hours of hospitalization. The proportion of progression in the 171 excluded patients was not significantly different (19.9%, Pϭ0.56). Patients with progressing lacunar infarct showed a higher prevalence of history of hypertension and higher leukocyte count on admission compared with those with nonprogressing stroke (Table  1) . No patients taking aspirin before the onset of stroke showed worsening of the neurological deficit. There were no significant differences between the 2 groups in lacunar syndromes at admission and stroke subtypes.
Among the factors potentially associated with neurological deterioration, blood glucose levels at 24 and 48 hours after admission were significantly higher in patients with progression (PՅ0.01), but systolic and diastolic blood pressures and body temperature were not ( Table 2 ). Other potential causes for infarct progression, such as decreased cardiac output, hypoxia for pulmonary reasons, seizures, or metabolic causes or infections, were not present or were present in similar proportions in both groups. There were no statistically significant differences in the proportion of patients receiving antihypertensive drugs, insulin, metamizol, paracetamol, antiplatelet drugs, sodium heparin, low-molecular-weight heparin, and other drug treatments.
The final neuroimaging test was CT scan in 63 patients and MRI in 50 patients. CT showed an acute lesion consistent with lacunar syndrome in 65% of patients; MRI, in 72%. Lacunar infarctions were located in the basal ganglia in 25 patients (1 in caudate, 11 in thalamus, and 13 in the lenticular nucleus), in supratentorial white matter in 42 (21 in internal capsule, 5 in corona radiata, and 16 in centrum semiovale), and in the brainstem in 10 patients (5 in pons, 3 in midbrain, and 2 in medulla). Old lacunar or territorial infarctions were seen in 42 and 11 patients, respectively. No differences in the frequency of old lesions were observed between the groups with and without acute lesions identified in the neuroimaging tests.
Early neurological deterioration occurred in 40% of patients with lacunar infarctions affecting the basal ganglia compared with only 9.5% of those located in white matter (Pϭ0.004) (Figure 1 ).
There was a 2-fold increase in plasma glutamate concentrations, a 3-fold decrease in GABA levels, and a 6-fold increase in the excitotoxic index in patients with neurological deterioration compared with those who improved or remained stable (all PϽ0.001). No differences in glycine levels were observed between the 2 groups of patients. Levels of GABA (PϽ0.001) but not of glutamate (Pϭ0.5) were significantly lower in nonprogressing lacunar stroke than the values obtained from our control group, which was not contemporary (Table 3) . Differences in plasma glutamate and GABA concentrations and in the excitotoxic index between patients with and without progressing stroke were found independently of the location of the lacunar infarction (Table 4) . We did not observe a linear correlation between glutamate or GABA concentrations and the degree of change in the CSS score 48 hours after admission. In fact, there was a sharp cutoff between concentrations in patients with progressing stroke and nonprogressing stroke estimated at 200 mol/L for glutamate and 240 nmol/L for GABA (Figure 2) . These values gave the highest positive predictive value (67% and 84%, respectively) and retained a high level of sensitivity (81% and 96%) and specificity (87% and 94%) for progression. The excitotoxic index was similar in patients with improving and stable lacunar infarctions but was higher in the group of patients showing more severe neurological worsening ( Figure 2 ). The positive predictive value, sensitivity, and specificity for progression of an excitotoxic index Ͼ106 were 85%, 89%, and 95%, respectively (Table 5) .
Glutamate concentrations Ͼ200 mol/L (OR, 30; 95%CI, 9 to 96) and GABA concentrations Ͻ240 nmol/L (OR, 421; 95%CI, 37 to 3771) but not a history of hypertension and increased leukocyte count on admission were independently and significantly associated with progressing stroke in the logistic regression analysis. There was no interaction between glutamate and GABA concentrations.
The prognosis of progressing lacunar infarctions was poor. At 3 months, dependency (modified Rankin scale Ͼ2) and a decrease in functional capacity (Barthel Index Ͻ85) were recorded in 44% and 44% of patients in the progressing group, whereas these figures were 13% and 15% in the nonprogressing group (all PϽ0.01).
Discussion
The present results confirm the high frequency of early progression of neurological deficit reported in previous studies in patients with lacunar infarction and strengthens its association with a more severe prognosis. [2] [3] [4] [5] [6] [7] [8] Despite the importance of the early clinical course on stroke outcome, no previous study has identified a clinical profile able to reliably predict which patients with lacunar infarct are likely to suffer neurological deterioration in the very early acute phase. Older and younger age, history of diabetes and arterial hyperten- sion, stroke severity, hyperglycemia within the first 2 days after admission, and larger infarct volume have been associated with lacunar stroke progression. [5] [6] [7] [8] However, the ability to predict progression on the basis of these clinical factors was estimated as being Ͻ60% in a large study based on a stroke data bank. 8 Our findings show that glutamate concentrations Ͼ200 mol/L and GABA concentrations Ͻ240 nmol/L in blood within the first 24 hours after the onset of symptoms (mean time from onset to sampling, 10.3Ϯ6.9 hours; range, 40 minutes to 24 hours) are powerful predictors of subsequent neurological deterioration. These factors correctly classified 86% and 95% of cases. No other clinical or baseline biochemical factors were independently associated with lacunar stroke progression.
The underlying mechanisms of early deterioration in lacunar infarctions are unknown. The extension of the infarcted area after a proximal occlusion of a perforating artery has been suggested as the main cause of progression. This hypothesis was supported by the finding that progressing lacunar infarctions were slightly larger than nonprogressing infarctions in a series of 92 patients, 7 and it has recently been observed by diffusion-weighted MRI in a single case report. 22 Although a thrombus propagation with progressive occlusion of branches arising from a large perforating artery has been proposed as an explanation for large (Ͼ15 mm in diameter) spreading lesions, 22 this mechanism is unlikely in the progression of small lacunes. Furthermore, the lack of collateral vessels for the perforating arteries causes a so-called "endartery" infarction in which the existence of a surrounding penumbra is improbable. In the present study, we did not find a higher frequency of proximal arterial stenosis; hence, it must be seriously doubted that the enlargement of the ischemic region may be attributed exclusively to a focal hemodynamic insufficiency. Values are expressed as meanϮSD. Conversely, the enlargement of cytotoxic edema showed by diffusion-weighted MRI and subsequent neurological worsening might be due to a delayed propagation of neuronal death mediated by multiple molecular and cellular mechanisms, such as excitotoxicity, free radical and nitric oxide generation, inflammation, and apoptosis. 23 Our findings suggest that an imbalance between the neurotoxic effects of glutamate and the neuroprotective effects of GABA might play a role in the pathophysiology of progressing lacunar stroke in the absence of relevant changes in cerebral blood flow.
Glutamate is released in high concentrations in the core of the cerebral infarction and in the penumbral cortex, leading to a massive influx of calcium that activates a variety of catabolic processes that subsequently produce cell death. 24 Plasma glutamate concentrations Ͼ200 mol/L within the first 24 hours of the onset of symptoms have been associated with subsequent progression of cortical and subcortical ischemic stroke, giving a 97% positive predictive value for neurological deterioration. 11, 25 Plasma glutamate levels may reflect the magnitude of glutamate accumulation in an ischemic brain. 26 This hypothesis is supported by the finding of a very high correlation between CSF and plasma concentrations of glutamate in human stroke 11 and the sharp increase in plasma glutamate found 4 hours after permanent middle cerebral artery (MCA) occlusion in a rat stroke model, which is not observed for other amino acids unrelated to the excitotoxic theory of stroke damage. 27 The role of glutamate in lacunar stroke is unknown because few patients were included in previous investigations. It has been proposed that glutamate does not exert a neurotoxic action in white matter ischemia because of a lack of synaptic glutamate receptors. 28 However, there is a high density of glutamatergic neurones in certain regions of the deep brain, such as the thalamus, striatum, or brainstem, where lacunar infarctions are frequently located. 29 In accordance with this anatomical distribution, the present results show that neurological deterioration is significantly less frequent in lacunar infarctions located in white matter (9.5%) than in those affecting basal ganglia (40%) and brainstem (50%). A further point of interest is that although mean glutamate concentrations in plasma are lower in lacunar infarctions than in territorial infarctions overall, 13 concentrations Ͼ200 mol/L are associated with neurological worsening. This cutoff in glutamate concentrations between patients with progressing and nonprogressing lacunar strokes has been described for cortical and subcortical large territorial infarctions. 11 This finding suggests that there is a similar threshold of glutamate neurotoxicity in lacunar and territorial infarctions and that glutamate accumulation within or outside the ischemic area does not depend exclusively on infarct volume.
GABA neurotransmission results in increased chloride flux across the postsynaptic membrane and hyperpolarization. 30 These actions counterbalance the toxic effects of glutamate during cerebral ischemia, as is supported by the neuroprotection of the GABA a receptor agonists in animal stroke models. 30 A sustained increase in GABA outflow in the ischemic brain has been detected by microdialysis after permanent MCA occlusion in rats 31 and after temporal lobe resection in humans. 32 In contrast, in the present study, we have found decreased plasma levels of GABA in patients with lacunar stroke compared with control subjects, a finding that agrees with the reduction in plasma and CSF levels of GABA detected in patients with acute ischemic stroke 33 and with the decrease in plasma GABA concentrations observed after global brain ischemia in cardiac surgery. 34 Although the dynamics of GABA are unknown, the present findings suggest a reduction in GABA-ergic neuronal activity, an increase in neuronal or glial GABA uptake, or an enhanced binding of GABA to its receptors in the ischemic brain, particularly in progressing lacunar infarctions. This later hypothesis could provoke a reversal inflow of GABA from blood across the disturbed blood-brain barrier or from the CSF to the brain tissue and consequently a reduction in GABA levels in these fluids.
The vulnerability of certain regions of the brain has been related to the varying distribution of the densities of glutamate and GABA a receptors. 30 In the same way, an excessive glutamate increase in the extracellular spaces, which is not compensated for by a parallel increase in GABA, might neutralize the cerebroprotective complex whose activation limits the extent of injury. In this study, the excitotoxic index had the highest positive predictive value for neurological deterioration. Most of its predictive power was given by the GABA concentrations because glutamate levels had a moderate predictive value (see Table 5 ). This finding supports the hypothesis that GABA plays a role in the modulation of anoxic injury in deep brain and white matter. 35 In contrast to our findings in cortical and subcortical territorial infarctions, 11, 13 plasma glycine concentrations in lacunar strokes were not higher than the control values and were not different between patients with progressing and nonprogressing lacunar strokes. The lack of coincidence in the results for lacunar and territorial infarctions cannot be attributed to a different interval from stroke onset to sampling because this interval was 10 hours in the present series and 11 hours in our previous study. 11 Increased levels of glycine in plasma were obtained 4 hours after permanent MCA occlusion in a rat stroke model, 27 so glycine levels in the brain are likely to be detected in peripheral blood in large infarctions. These data suggest that the discrepancy might be explained by a smaller release of glycine in small infarctions.
Although an acute-phase reaction or systemic causes cannot be ruled out as producing an increase in plasma glutamate levels and a decrease in plasma GABA concentrations, several facts support the hypothesis that these changes are a reflection of the dynamics of neurotransmitters in the ischemic brain. GABA levels were particularly reduced (3-fold) and glutamate levels were increased (2-fold) in patients with subsequent progressing lacunar strokes in whom cardiovascular risk factors, stroke severity, stroke cause, biochemical parameters, and vital signs evaluated at the moment in which blood samples were taken (before progression) were similar to those of the nonprogressing group. Consequently, we cannot attribute differences in neurotransmitter concentrations to a different acute-phase response or to a distinct prior comorbidity. Furthermore, fever and other medical complications showed a similar frequency between groups, so differences in GABA and glutamate levels cannot be explained by biochemical responses to systemic problems after admission.
In conclusion, our findings suggest that an imbalance between excitatory and inhibitory neurotransmitters plays a role in the pathophysiology of progressing lacunar infarctions. However, it should be made clear that this remains to be proved because our study was not designed to investigate the mechanistic relationship between excitatory and inhibitory amino acid levels found in plasma and phenomena occurring in the brain. The excitotoxic index may be useful for the early detection of those patients with lacunar infarcts experiencing motor function deterioration in the 48 hours after admission. The effectiveness of the use of the excitotoxic index in the selection of patients with lacunar syndromes for neuroprotective interventions should be investigated.
